Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
7.48
-0.12 (-1.58%)
Mar 3, 2026, 4:00 PM EST - Market closed

Cartesian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
195461112173403327
Market Cap Growth
-60.27%313.44%-35.45%-57.09%23.07%59.38%
Enterprise Value
63.73262.87346.2276.26310.24224.12
Last Close Price
7.4817.9120.6833.9097.8090.90
PE Ratio
--3.99-0.42339.00-444.55-4.46
PS Ratio
178.2811.864.291.564.7419.73
PB Ratio
--67.85-0.251.8417.89-18.19
P/TBV Ratio
-5.43-45.70-0.2452.71496.49-17.03
P/FCF Ratio
--14.08-2.17-5.27-6.569.61
P/OCF Ratio
--19.49-2.18-5.47-6.679.39
EV/Sales Ratio
58.416.7613.310.693.6513.50
EV/EBITDA Ratio
--6.15-4.054.82-92.75-4.00
EV/EBIT Ratio
--5.99-4.015.25-67.49-3.94
EV/FCF Ratio
--8.02-6.74-2.32-5.056.58
Debt / Equity Ratio
-0.35-2.06-0.080.401.57-1.96
Debt / EBITDA Ratio
-0.11-0.33-0.132.40-10.55-0.63
Debt / FCF Ratio
-0.18-0.43-0.21-1.15-0.571.04
Net Debt / Equity Ratio
3.6529.200.15-1.03-4.125.74
Net Debt / EBITDA Ratio
1.184.650.77-6.1127.741.84
Net Debt / FCF Ratio
1.906.061.282.951.51-3.03
Asset Turnover
0.000.110.110.680.520.13
Quick Ratio
10.449.291.265.761.911.79
Current Ratio
10.679.431.335.912.001.86
Return on Equity (ROE)
225.01%105.75%959.08%60.82%-1137.85%1433.57%
Return on Assets (ROA)
-28.06%-11.91%-33.78%9.08%-7.47%-42.88%
Return on Invested Capital (ROIC)
-52.77%-21.01%-70.29%77.95%-61.93%-820.82%
Return on Capital Employed (ROCE)
-29.40%-13.53%-45.77%12.73%-5.36%-76.52%
Earnings Yield
-24.67%-25.07%-240.62%0.29%-0.22%-22.44%
FCF Yield
-35.42%-7.10%-46.02%-18.98%-15.25%10.40%
Buyback Yield / Dilution
0.02%-27.84%5.32%-22.74%-13.13%-4.19%
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q